Assistant Professor at University of Tabuk in Saudi Arabia.
Dr. Naveed Ahmed is a distinguished scientist in Medical Microbiology whose research seamlessly blends laboratory science with clinical impact. Currently serving as Assistant Professor at the University of Tabuk, Saudi Arabia, he earned his Ph.D. from Universiti Sains Malaysia, where he was recognized for academic excellence and timely graduation. His work spans infectious disease diagnostics, antimicrobial resistance mechanisms, nanomedicine applications, and computational vaccine design. With over 46 Q1/Q2 publications, an H-index of 23, Dr. Ahmed has contributed to global health datasets and collaborative studies published in top-tier journals such as The Lancet. His innovations include patented laboratory protocols for microbial diagnostics and immune profiling. Known for his capacity to integrate molecular methods, bioinformatics, and translational science, Dr. Ahmed’s career reflects both depth of expertise and breadth of interdisciplinary collaboration, making him a prominent figure in the global fight against infectious diseases.
Professional Profile
Scopus | Google Scholar | ORCID
Education
Dr. Ahmed holds a Doctor of Philosophy in Medical Microbiology from Universiti Sains Malaysia. His doctoral research, supported by competitive scholarships and awards, focused on molecular pathogenesis of Epstein–Barr Virus-associated cancers and immune checkpoint modulation. Prior to his Ph.D., he earned a Master of Science in Microbiology from the University of Central Punjab, Pakistan, where he developed expertise in bacteriology, immunology, and clinical diagnostics. His academic journey began with a BS (Honors) in Medical Laboratory Technology from the University of the Punjab, Pakistan, where he cultivated laboratory proficiency and research skills. Throughout his education, Dr. Ahmed actively engaged in research projects, academic presentations, and interdisciplinary collaborations, laying a foundation for high-impact publications and translational innovations. This diverse and rigorous educational background enables him to tackle complex biomedical challenges through both experimental and computational approaches.
Experience
Dr. Ahmed’s professional trajectory blends academic teaching, laboratory management, and high-impact research. As Assistant Professor at the University of Tabuk, he teaches undergraduate and diploma-level courses, designs curricula, and fosters research collaborations with international teams. Previously, as a Graduate Research Assistant at Universiti Sains Malaysia, he managed grant-funded projects, secured ethical clearances, coordinated multi-institutional studies, and delivered results published in Q1/Q2 journals. Earlier roles as Laboratory Technologist at the Pakistan Kidney and Liver Institute and as Microbiology Supervisor at Chughtai Lab honed his expertise in clinical diagnostics, antimicrobial stewardship, biosafety, and ISO 15189 implementation. His teaching experience includes visiting lectureships at the University of Central Punjab and Imperial College of Business Studies. Across all roles, Dr. Ahmed has demonstrated leadership in laboratory innovation, research project management, and academic mentorship, ensuring his contributions extend from the bench to the classroom and into public health policy.
Research Focus
Dr. Ahmed’s research focuses on the intersection of microbial pathogenesis, diagnostics, and therapeutic innovation. His investigations into antimicrobial resistance encompass genetic profiling of multidrug-resistant pathogens, elucidating resistance mechanisms induced by heavy metal exposure, and identifying virulence factors in hospital-acquired infections. In virology, he has advanced understanding of Epstein–Barr Virus latency genes and their role in immune checkpoint regulation, with implications for immunotherapy. He also explores nanomedicine, developing carbon-based nanomaterials and bioactive microbial compounds as diagnostic and therapeutic agents against cancer. His computational vaccine design projects leverage immunoinformatics to engineer multi-epitope vaccines targeting high-burden pathogens. Additionally, Dr. Ahmed contributes to global health surveillance datasets, applying systematic review and meta-analysis methods to epidemiological trends. His integrative approach combines molecular biology, bioinformatics, and translational science, aiming to bridge laboratory research with deployable healthcare solutions that address both infectious diseases and oncology in resource-diverse settings.
Awards & Honors
Dr. Ahmed’s achievements are recognized through numerous competitive awards. He received the Graduate on Time Award (2024) and was nominated for the Best Ph.D. Thesis Award at Universiti Sains Malaysia. His presentation skills earned him 2nd place and the Young Investigator Award at the 9th Regional Conference on Molecular Medicine (2023). He twice won the prestigious Sanggar Sanjung Award (2021, 2022) for best publication-based research among USM students and was recognized as Best Oral Presenter in the departmental journal club (2022). Early in his career, he won Best Poster Presentation at the Annual Conference of Medical Microbiology and Infectious Diseases Society of Pakistan (2020). His research funding success includes grants from the Malaysian Ministry of Higher Education and industry collaborations with Medical Innovation Ventures. Combined with international fellowships and professional memberships, these honors underscore his sustained excellence in research, innovation, and scholarly dissemination.
Publication Top Notes
Title: The Microbial Sources of Bioactive Compounds: Potential Anticancer Therapeutic Options
Authors: Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., Sohail, Z., Singh, K. K. B., Baig, A. A., & Yean, C. Y.
Journal: Nano Life, Vol. 15, 2430007.
Summary: Microbial metabolites from bacteria and fungi were isolated, characterized, and screened for anticancer activity. Several showed high selectivity and strong molecular target binding, offering sustainable leads for oncology drug development.
Title: Carbon-based Nanomaterials as Multifunctional Particles for Cancer Diagnosis and Treatment
Authors: Ahmed, N., Abusalah, M. A. H. A., Absar, M., Noor, M. S., Bukhari, B., Anjum, S. A., Singh, K. K. B., & Yean, C. Y.
Journal: Nano Life, Vol. 15, 2430005.
Summary: Graphene oxide, carbon nanotubes, and fullerenes were functionalized for targeted cancer imaging and therapy. They enabled enhanced tumor visualization, sustained drug release, and effective photothermal/photodynamic treatment, advancing nanotheranostic applications.
Title: Immunoinformatic Execution and Design of an Anti–Epstein–Barr Virus Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses
Authors: Ahmed, N., Rabaan, A. A., Alwashmi, A. S., et al.
Journal: Microorganisms, Vol. 11, 2448.
Summary: A computational pipeline identified epitopes from EBV latent and lytic proteins, modeled their MHC binding, and simulated strong immune responses. Codon optimization suggested efficient bacterial expression, supporting rapid vaccine prototyping.
Title: Heavy Metal (Arsenic) Induced Antibiotic Resistance among Extended-Spectrum β-Lactamase (ESBL) Producing Bacteria of Nosocomial Origin
Authors: Ahmed, N., Tahir, K., Aslam, S., et al.
Journal: Pharmaceuticals, Vol. 15, 1426.
Summary: Arsenic in hospital effluents was linked to co-selection of plasmid-borne ESBL and arsenic resistance genes. This co-resistance highlights environmental drivers of antimicrobial resistance and the need for better wastewater control.
Title: Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
Authors: Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., et al.
Journal: Medicina, Vol. 59, Issue 2.
Summary: This review outlines how EBV latent proteins like LMP1 and EBNA1 drive oncogenesis, evade immunity, and present therapeutic targets, emphasizing potential immunotherapy approaches for endemic regions.
Title: The Antimicrobial Efficacy against Selective Oral Microbes, Antioxidant Activity and Preliminary Phytochemical Screening of Zingiber officinale
Authors: Ahmed, N., Karobari, M. I., Yousaf, A., et al.
Journal: Infection and Drug Resistance,pp. 2773–2785.
Summary: Methanolic and aqueous ginger extracts inhibited oral pathogens and showed strong antioxidant activity linked to high phenolic and flavonoid content, supporting its use in oral health products.
Title: Antibiotic Resistance Profile in Relation to Virulence Genes fimH, hlyA and usp of Uropathogenic E. coli Isolates in Lahore, Pakistan
Authors: Ahmed, N., Zeshan, B., Naveed, M., et al.
Journal: Tropical Biomedicine, Vol. 36, pp. 559–568.
Summary:In clinical isolates, fimH and hlyA genes correlated with multidrug resistance. The findings stress the dual risk of resistance and virulence in urinary tract infections.
Conclusion
Dr. Naveed Ahmed possesses the academic excellence, research productivity, and global engagement expected of a Best Researcher Award recipient. His combination of high-impact publications, patents, conference recognition, and international collaborations demonstrates a clear commitment to advancing knowledge and innovation in medical microbiology and infectious diseases. With continued emphasis on leadership in large-scale research initiatives and translational impact, he is exceptionally well-suited for this award and has strong potential to contribute even more significantly to the scientific community in the future.
